These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 25990344
1. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. Mahfoud F, Böhm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, Tsioufis K, Andersson B, Blankestijn PJ, Burnier M, Chatellier G, Gafoor S, Grassi G, Joner M, Kjeldsen SE, Lüscher TF, Lobo MD, Lotan C, Parati G, Redon J, Ruilope L, Sudano I, Ukena C, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W, Zeller T, Schmieder RE. Eur Heart J; 2015 Sep 01; 36(33):2219-27. PubMed ID: 25990344 [No Abstract] [Full Text] [Related]
4. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation. Patel P, Gupta PK, White CM, Stanley AG, Williams B, Tomaszewski M. J Hum Hypertens; 2016 Jun 01; 30(6):368-73. PubMed ID: 26446393 [Abstract] [Full Text] [Related]
5. Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications. Mahfoud F, Weber M, Schmieder RE, Lobo MD, Blankestijn PJ, Persu A, Fischell TA, Parise H, Pathak A, Kandzari DE. Am Heart J; 2021 Sep 01; 239():90-99. PubMed ID: 34052211 [Abstract] [Full Text] [Related]
6. Resistant Hypertension in a Patient With Chronic Type B Aortic Dissection. A Selective Indication for Renal Artery Denervation Treatment. Trabattoni D, Galli S, Rogacka R, Teruzzi G, Montorsi P. Am J Hypertens; 2020 Aug 04; 33(8):784-787. PubMed ID: 32307546 [No Abstract] [Full Text] [Related]
8. Renal Denervation: Where to Now? Wimmer NJ, Mauri L. Curr Cardiol Rep; 2015 Dec 04; 17(12):116. PubMed ID: 26482759 [Abstract] [Full Text] [Related]
9. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation? Epstein M, de Marchena E. J Am Soc Hypertens; 2015 Feb 04; 9(2):140-9. PubMed ID: 25649995 [Abstract] [Full Text] [Related]
12. [Renal sympathetic denervation in refractory hypertension]. Sans Atxer L, Oliveras A. Med Clin (Barc); 2013 Mar 16; 140(6):263-5. PubMed ID: 23276614 [No Abstract] [Full Text] [Related]
13. Now That Renal Denervation Works, How Do We Proceed? Papademetriou V, Stavropoulos K, Doumas M, Tsioufis K. Circ Res; 2019 Mar 16; 124(5):693-695. PubMed ID: 30817252 [No Abstract] [Full Text] [Related]